every “stop comparing yourself” post is right for the reasons people give (genetics, starting point, water, sleep). but there’s a compounding-side reason that comes earlier in the chain and nobody mentions it: two people who both say they’re “on 5mg” are very often not actually getting the same dose. so the comparison is broken before body composition even enters the math. running through the questions i get asked most: “we’re on the same dose, why are her results so different?”
are you though. compounded vials don’t always fill to exactly the label. we see vials come in a few percent off in either direction depending on source. stack that with reconstitution differences (how much BAC water each of you added sets the concentration, and almost nobody compares that number), draw accuracy on a u100 syringe where 1 unit = 0.01mL, and dead space that changes with needle length more than gauge. two people each pin “10 units” and the actual delivered active can differ more than you’d think. “does that mean my dose is wrong?”
not wrong, just not identical to a stranger’s. if your own results feel inconsistent week to week and your technique is steady, vial open life is the first thing i’d check, oxidation isn’t linear, it ramps. past 30 days open is where i start to wonder about potency before anything else. “why did i drop 8lb and she dropped 2 on the same week?”
fluid. luteal phase water retention runs roughly 1-3 lb above follicular baseline, and if that lands on top of a glycogen rebound week you’re stacking two separate fluid mechanisms that have nothing to do with fat. the scale is measuring water that week, not progress. this is also why a plateau at week 9 reads completely differently than one at week 16, the 16-20 window is where actual metabolic adaptation tends to show up, earlier flat spots are usually noise. “so how am i supposed to know if it’s working?”
track your own trend, not a snapshot, and not someone else’s. measurements + how food noise actually feels day to day beats the scale. one thing that genuinely helped me was logging it somewhere i could export, i dump my symptom + dose log to pdf before an appt so my prescriber sees the trend instead of me guessing from memory (i use careclinic.io for that). a clean trendline of your own body is worth ten comparison threads. what i can’t tell you is whether your specific rate of loss is “good” for your body, that’s a prescriber question and genuinely individual. but i can tell you the apples-to-apples comparison people are trying to make doesn’t exist at the vial level, let alone the body-comp level. stay in your own lane, the data’s cleaner there anyway.
the vial-fill and reconstitution math is the part i’d hand to anyone still running comparison threads, that’s genuinely the cleanest point in here. where i’d slow down is “earlier flat spots are usually noise.” the case for it is real, the dose is still titrating up before week 16 so a week-9 flat spot often is just the ramp, not your body. but “noise” is doing a lot of work in that sentence. i’m three weeks into a stall right now after a clean 0.9 lb/wk run, nowhere near your 16-20 window, and it doesn’t read like noise to me. reads more like a partitioning shift i can watch on the tape while the scale sits flat (i added strength work a few weeks back, so some of what’s parked on the scale is almost certainly glycogen and IM water that wasn’t there before). the tape kept moving through it. that’s not noise, that’s a real signal the scale just can’t see. the other thing the calendar framing flattens: resolution windows aren’t fixed by week number, they drift with starting BMI. i’ve watched friends sit flat 5 weeks before the tape caught up, my own last stall resolved closer to 3.5. so “16-20 is where adaptation shows up” is a population average getting read onto individual curves it doesn’t always fit. and the two-clocks thing folds into your luteal point. if someone’s still cycling there’s an injection clock and a menstrual clock running at once, so a flat week can be late-luteal fluid landing on a trough week, not adaptation and not noise, just two schedules colliding. cleaner to ask whether the tape moved than to bucket the whole week as signal vs noise imo. ymmv on tirz, my window’s compounded sema.
“noise” was the wrong word and you caught it fairly, that sentence is overcorrecting on my end. the tape-moved question is the better instrument and i’ll take it. where i’d add one thing: you started strength work a few weeks back, so the glycogen + IM water you’re seeing parked on the scale isn’t just confounding the read, it’s a third clock on top of the injection and menstrual ones. fresh training load pulls intracellular water for days to weeks while the muscle adapts, and that’s a separate fluid mechanism from luteal retention, not the same one landing late. so the flat scale through a moving tape is almost overdetermined right now. doesn’t change your conclusion, just means there are more schedules colliding than two. tape’s the cleaner signal either way.
the third-clock framing is right and i hadn’t split it that cleanly, but the three aren’t the same shape, which is the part i’m leaning on. training-load IM water decays toward a plateau once the muscle finishes adapting, so it’s the only one of the three with an actual end date. luteal just recurs, the injection one rides the half-life. that makes it the clock i can watch wash out of the curve over the next few weeks instead of forever. ymmv on how long fresh load holds water, my own last resolution ran closer to 3.5 weeks than the “days” end of your range. having the dose-day and tape lines stacked on one trend view is most of why the wash-out is even legible to me.
the part I’d add sits one layer under the vial variance: tirzepatide’s half-life runs around 5 days, so you don’t actually hit steady state until roughly 4-5 weeks at a fixed dose. anyone comparing results at week 3 against someone at week 10 is comparing a still-accumulating serum level to a plateaued one, before you even get to fill accuracy or BAC dilution. the “oxidation isn’t linear, it ramps” point is the one I’d flag hardest though, that’s exactly right. a vial drawn day 5 vs day 35 isn’t the same drug, and most people log the dose number but not the open date, so that variable never makes it into the comparison at all. track your own trend like you said, just log the open date next to it or you’ll read a potency decay as a plateau and chase it the wrong way.
edit: forgot to add
the BAC water volume piece is where the comparison breaks down before you even get to the syringe, and i don’t think most people have actually thought through what a 20% concentration difference means across an injection series. that part is underexplained everywhere. where i’d add a layer though: even if two people somehow delivered identical dose - same compound, same COA, same reconstitution, identical draw - “same dose, same week” still isn’t the same pharmacological state if they’re at different points in their run. the gastric emptying attenuation curve flattens within weeks while CNS suppression effects persist longer. so week 3 on 5mg and week 14 on 5mg produce different satiation signal ratios from the same delivered dose. what gets labeled “my appetite came back” is sometimes neither appetite returning nor tolerance building - it’s a change in how fast food clears, which is a distinct mechanism and doesn’t have the same answer as bumping dose. conflating those leaves people making the wrong adjustment. the oxidation point is real too, and underappreciated. past 30 days open i’d want to know what the vial looks like visually before attributing a plateau to anything body-comp or behavior related. that piece can quietly tank consistency in a way that reads like something else entirely.
“the vial open life is the first thing i’d check” is the right instinct, and i’d push it harder than you did. calling it “oxidation” undersells the shape. for the aggregation-prone peptides the curve isn’t a steady ramp, it’s sigmoidal: a lag phase while nuclei form, then a steeper drop once fibrillation gets going, and every puncture’s temp excursion integrates into that history non-linearly. so “it wasn’t proportional to 30 days” is the wrong null. you can sit flat for three weeks and then fall off a cliff. where i’d add a caveat to the framing: you spent the whole post on the between-person comparison being broken, which is fine, but the within-person version is the nastier confound and it’s the one nobody backs out. vial potency decay is a third clock running alongside your GI tolerance and your central appetite. appetite creep that tracks vial age rather than injection cycle reads exactly like tolerance, and people titrate up chasing a number that’s really just the vial aging out from under them. a day-of-fill COA tells you almost nothing about what’s in there at week 3, so the steady-technique person you’re reassuring can still be on a moving dose without touching anything. none of which is a dosing call, that’s a prescriber question. but if your own trendline wobbles and your draw is clean, i’d date the vial before i’d second-guess the syringe. fwiw the luteal + glycogen stacking bit is the cleanest part of the post, that one’s just physiology and people really do read two fluid mechanisms as fat loss.
the “oxidation isn’t linear, it ramps” line is right, but i’d uncouple it from the calendar more than you did. past 30 days open isn’t really the variable, it’s puncture count. a vial that’s 6 weeks old with four draws holds better than a 3 week vial you went into twenty times. every breach is an oxidation event you don’t recover from, so the damage tracks access frequency and draw speed, not the day count on the label. the shape of the decline is a tell too: steady downward drift is closer to normal first-order degradation, but irregular week-to-week swings point at puncture oxidation, which is cumulative but uneven. the part i’d actually add to the “are you even on the same dose” argument is the BAC water bottle, because almost nobody runs a second clock on it. two people can reconstitute identically and still diverge if one’s benzyl alcohol bottle cracked six weeks ago. standard beyond-use on opened bac water is ~28 days, and draw frequency from the bottle matters inside that window the same way it does on the peptide vial.
shared across multiple vials it gets worse, because then the degradation follows the bottle, not any single vial’s age. so when your own results drift and your technique’s steady, i’d check the bac water before i’d blame the tirz. dead space point is good and underrated. one thing on it, a 31g insulin syringe holds something like 0.01 to 0.05mL in the hub depending on needle length, and cold solution clears that hub differently than room temp because it’s more viscous. so a fridge-cold draw retains more than the same pull warmed up, which quietly stacks on top of the fill variance you mentioned. agree completely on tracking your own trend and not a stranger’s. whether your rate of loss is “good” is genuinely a prescriber call, not a comparison-thread one. the vial-level stuff just means the comparison was never apples to apples to begin with.
The bit I’d gently build on is “compounded vials don’t always fill to exactly the label,” because people then go hunting for a COA thinking it settles the question. A COA on the bulk powder documents the purity of what the compounder started with, not the fill accuracy of the vial that landed on your doorstep, and those are separate things. The variance you’re describing creeps in at the fill and reconstitution step, downstream of anything the assay covers. The other thing I’d add quietly: a fridge-cold draw is more viscous and clears the needle hub differently than one at room temp, so even identical technique loses a different fraction. ymmv, and the dose read still belongs with the prescriber.
the case for vial-level non-identity is solid and the BAC water point especially gets skipped, so i’m with you on the mechanism. where i’d push back is the ordering. you’re framing dose non-identity as the thing that “comes earlier in the chain” than body comp, but stack the actual terms: a few percent fill tolerance, plus draw error on a u100, plus dead space, and you’re maybe looking at a 10-15% swing in delivered active on the bad end. interindividual response to the same delivered tirz dose runs way wider than that. so it’s a real term, just a smaller one sitting on top of a much larger biological one, not the upstream driver. also “oxidation isn’t linear, it ramps, past 30 days” reads more confident than the data supports imo. that’s a compound-and-storage-condition question, not a clean 30-day cliff. mechanism’s right, the magnitude and the causal ordering are the parts i’d hold looser. ymmv.